Format
Sort by
Items per page

Send to

Choose Destination

See also: DICER1 dicer 1, ribonuclease III in the Gene database

dicer1 in Homo sapiensMus musculusRattus norvegicusAll 282 Gene records

Search results

Items: 1 to 20 of 1305

1.

Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer.

Ren W, Zhang X, Li W, Feng Q, Feng H, Tong Y, Rong H, Wang W, Zhang D, Zhang Z, Tu S, Zhu X, Zhang Q.

Cancer Manag Res. 2019 May 6;11:4023-4040. doi: 10.2147/CMAR.S198886. eCollection 2019.

PMID:
31190980
2.

Endo-siRNAs repress expression of SINE1B during in vitro maturation of porcine oocyte.

Kong QR, Zhang JM, Zhang XL, Zong M, Zheng KL, Liu L, Meng FX, Zhang TT, Weng XG, Mu YS, Liu ZH.

Theriogenology. 2019 May 22;135:19-24. doi: 10.1016/j.theriogenology.2019.05.011. [Epub ahead of print]

PMID:
31189122
3.

ADAR and Immune Silencing in Cancer.

Herbert A.

Trends Cancer. 2019 May;5(5):272-282. doi: 10.1016/j.trecan.2019.03.004. Epub 2019 May 3. Review.

PMID:
31174840
4.

Survival of Naïve T Cells Requires the Expression of Let-7 miRNAs.

Pobezinskaya EL, Wells AC, Angelou CC, Fagerberg E, Aral E, Iverson E, Kimura MY, Pobezinsky LA.

Front Immunol. 2019 May 3;10:955. doi: 10.3389/fimmu.2019.00955. eCollection 2019.

5.

Intraocular medulloepithelioma - A review of clinical features, DICER 1 mutation, and management.

Tadepalli SH, Shields CL, Shields JA, Honavar SG.

Indian J Ophthalmol. 2019 Jun;67(6):755-762. doi: 10.4103/ijo.IJO_845_19. Review.

6.

Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.

Durmuş Y, Kılıç Ç, Çakır C, Yüksel D, Boran N, Karalök A, Boyraz G, Turan AT.

J Obstet Gynaecol Res. 2019 May 20. doi: 10.1111/jog.13977. [Epub ahead of print]

PMID:
31106943
7.

Practical Review of Ovarian Sex Cord-Stromal Tumors.

Hanley KZ, Mosunjac MB.

Surg Pathol Clin. 2019 Jun;12(2):587-620. doi: 10.1016/j.path.2019.02.005. Review.

PMID:
31097116
8.

Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.

Yi L, Luo P, Zhang J.

J Cell Biochem. 2019 May 12. doi: 10.1002/jcb.28904. [Epub ahead of print]

PMID:
31081184
9.

Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma.

Yin L, He N, Chen C, Zhang N, Lin Y, Xia Q.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1908-1916. doi: 10.1080/21691401.2019.1613421.

PMID:
31072138
10.

Mesenchymal Hamartoma of the Liver and DICER1 Syndrome.

Apellaniz-Ruiz M, Segni M, Kettwig M, Glüer S, Pelletier D, Nguyen VH, Wagener R, López C, Muchantef K, Bouron-Dal Soglio D, Sabbaghian N, Wu MK, Zannella S, Fabian MR, Siebert R, Menke J, Priest JR, Foulkes WD.

N Engl J Med. 2019 May 9;380(19):1834-1842. doi: 10.1056/NEJMoa1812169.

PMID:
31067372
11.

Genetic variants in DICER1, DROSHA, RAN, and XPO5 genes and risk of pregnancy-induced hypertension.

Huang X, An Y, Li X, Wang D, Tan H, Lei J.

Pregnancy Hypertens. 2019 Apr;16:161-166. doi: 10.1016/j.preghy.2019.04.005. Epub 2019 Apr 16.

PMID:
31056154
12.

Germline DICER1-mutant intracranial sarcoma with dual chondroid and spindle cell morphology and pulmonary metastases treated with multimodal therapy.

Das A, Roy P, Modi SK, Achari RB, Sen S, Singh A, Sukumaran R, Bhattacharyya A.

Pediatr Blood Cancer. 2019 Jul;66(7):e27744. doi: 10.1002/pbc.27744. Epub 2019 Apr 16. No abstract available.

PMID:
30989777
13.

DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.

Karnezis AN, Wang Y, Keul J, Tessier-Cloutier B, Magrill J, Kommoss S, Senz J, Yang W, Proctor L, Schmidt D, Clement PB, Gilks CB, Huntsman DG, Kommoss F.

Am J Surg Pathol. 2019 May;43(5):628-638. doi: 10.1097/PAS.0000000000001232.

PMID:
30986800
14.

CFTR mutation compromises spermatogenesis by enhancing miR-15b maturation and suppressing its regulatory target CDC25A.

Chen Y, Li X, Liao H, Leung X, He J, Wang X, Li F, Yue H, Xu W.

Biol Reprod. 2019 Apr 15. pii: ioz062. doi: 10.1093/biolre/ioz062. [Epub ahead of print]

PMID:
30985893
15.

Genetic profiling of rhabdomyosarcoma with clinicopathological and radiological correlation.

Albalawi ED, Alkatan HM, Elkhamary SM, Safieh LA, Maktabi AMY.

Can J Ophthalmol. 2019 Apr;54(2):247-257. doi: 10.1016/j.jcjo.2018.03.011. Epub 2018 May 18.

PMID:
30975350
16.

Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.

Ramírez-Moya J, Wert-Lamas L, Riesco-Eizaguirre G, Santisteban P.

Oncogene. 2019 Apr 9. doi: 10.1038/s41388-019-0804-8. [Epub ahead of print]

PMID:
30967628
17.

DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions.

Poma AM, Condello V, Denaro M, Torregrossa L, Elisei R, Vitti P, Basolo F.

Oncotarget. 2019 Mar 5;10(19):1785-1797. doi: 10.18632/oncotarget.26639. eCollection 2019 Mar 5.

18.

An update on the central nervous system manifestations of DICER1 syndrome.

de Kock L, Priest JR, Foulkes WD, Alexandrescu S.

Acta Neuropathol. 2019 Apr 5. doi: 10.1007/s00401-019-01997-y. [Epub ahead of print] Review.

PMID:
30953130
19.

Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report.

Osakabe M, Sato C, Suzuki M, Sugimoto R, Fujita Y, Uesugi N, Ishida K, Itamochi H, Baba T, Sugai T.

Diagn Pathol. 2019 Apr 1;14(1):27. doi: 10.1186/s13000-019-0805-5.

20.

Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.

Aryal NK, Pant V, Wasylishen AR, Rimel BJ, Baseler L, El-Naggar AK, Mutch DG, Goodfellow PJ, Arur S, Lozano G.

Cancer Res. 2019 May 15;79(10):2662-2668. doi: 10.1158/0008-5472.CAN-18-2460. Epub 2019 Mar 26.

PMID:
30914430

Supplemental Content

Loading ...
Support Center